Proximal colon cancers are more likely than rectal and distal colon tumors to have microsatellite instability, a CpG island methylator phenotype, and KRAS mutations, whereas rectal and distal colon tumors are more likely than proximal colon tumors to have TP53 and APC mutations [42]. Here, TP53 is linked to malignant colon neoplasm.